TREATMENT FOR OSTEOPOROSIS USING GROWTH HORMONE RELEASE FACTOR (GRF) IN COMBINATION WITH PARATHYROID HORMONE (PTH)

摘要

A method of treating osteoporosis, especially post-menopausal osteoporosis, byadministering on a periodic but regular ba-sis to a patient growth hormone releasing factor, GRF(1-44)-NH2, or abiologically active analog thereof, and concurrently ad-ministering parathyroid hormone, PTH(1-34)-NH2 and continuing theadministration until bone mass increases and the pa-tient's calcium balance becomes positive and indicates a mineral accumulationin the skeleton.